Tempus AI (NASDAQ:TEM) Rating Lowered to Neutral at Bank of America

Bank of America cut shares of Tempus AI (NASDAQ:TEM) from a buy rating to a neutral rating in a report released on Wednesday morning, Marketbeat.com reports. The firm currently has $60.00 price target on the stock, up from their prior price target of $45.00.

Several other analysts have also issued reports on the stock. Piper Sandler began coverage on shares of Tempus AI in a research report on Monday, August 12th. They set a neutral rating and a $40.00 price target on the stock. Loop Capital started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a buy rating and a $48.00 target price on the stock. JPMorgan Chase & Co. lifted their price target on Tempus AI from $42.00 to $47.00 and gave the stock an overweight rating in a report on Wednesday, August 7th. Morgan Stanley started coverage on Tempus AI in a research report on Tuesday, July 9th. They set an overweight rating and a $44.00 price target on the stock. Finally, Longbow Research assumed coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a buy rating and a $48.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average target price of $47.67.

Tempus AI Trading Up 8.1 %

TEM opened at $52.94 on Wednesday. The stock’s 50-day moving average is $50.81. Tempus AI has a 52-week low of $22.89 and a 52-week high of $77.00. The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to analysts’ expectations of $159.10 million. As a group, research analysts predict that Tempus AI will post -6.51 earnings per share for the current year.

Institutional Trading of Tempus AI

Several institutional investors have recently added to or reduced their stakes in TEM. Sandia Investment Management LP bought a new position in Tempus AI during the second quarter worth about $136,000. Northwestern University acquired a new stake in shares of Tempus AI in the 2nd quarter valued at approximately $491,000. Squarepoint Ops LLC acquired a new stake in Tempus AI in the second quarter valued at approximately $633,000. WINTON GROUP Ltd acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $634,000. Finally, Scientech Research LLC bought a new stake in shares of Tempus AI during the second quarter worth about $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.